2vti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{Seed}} | |||
[[Image:2vti.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_2vti", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_2vti| PDB=2vti | SCENE= }} | |||
===IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.=== | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed | ==About this Structure== | ||
2VTI is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VTI OCA]. | |||
[[Category: Homo sapiens]] | |||
[[Category: Single protein]] | |||
[[Category: Berdini, V.]] | |||
[[Category: Boulstridge, J A.]] | |||
[[Category: Brien, M A.O.]] | |||
[[Category: Carr, M G.]] | |||
[[Category: Cross, D M.]] | |||
[[Category: Danillon, D.]] | |||
[[Category: Davis, D J.]] | |||
[[Category: Devine, L A.]] | |||
[[Category: Early, T R.]] | |||
[[Category: Feltell, R E.]] | |||
[[Category: Lewis, E J.]] | |||
[[Category: Mcmenamin, R L.]] | |||
[[Category: Navarro, E F.]] | |||
[[Category: Reilly, M O.]] | |||
[[Category: Reule, M.]] | |||
[[Category: Saxty, G.]] | |||
[[Category: Seavers, L C.A.]] | |||
[[Category: Smith, D M.]] | |||
[[Category: Squires, M S.]] | |||
[[Category: Trewartha, G.]] | |||
[[Category: Walker, M T.]] | |||
[[Category: Woodhead, A J.]] | |||
[[Category: Woolford, A J.A.]] | |||
[[Category: Wyatt, P G.]] | |||
[[Category: Atp-binding]] | |||
[[Category: Cell cycle]] | |||
[[Category: Cell division]] | |||
[[Category: Fragment screening]] | |||
[[Category: Kinase]] | |||
[[Category: Mitosis]] | |||
[[Category: Nucleotide-binding]] | |||
[[Category: Phosphoprotein]] | |||
[[Category: Phosphorylation]] | |||
[[Category: Polymorphism]] | |||
[[Category: Protein kinase]] | |||
[[Category: Serine/threonine protein kinase]] | |||
[[Category: Serine/threonine-protein kinase]] | |||
[[Category: Structure based drug design]] | |||
[[Category: Transferase]] | |||
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug 6 12:50:24 2008'' |
Revision as of 12:50, 6 August 2008
IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6-DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519), A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN.
About this StructureAbout this Structure
2VTI is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Page seeded by OCA on Wed Aug 6 12:50:24 2008
Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)
OCACategories:
- Pages with broken file links
- Homo sapiens
- Single protein
- Berdini, V.
- Boulstridge, J A.
- Brien, M A.O.
- Carr, M G.
- Cross, D M.
- Danillon, D.
- Davis, D J.
- Devine, L A.
- Early, T R.
- Feltell, R E.
- Lewis, E J.
- Mcmenamin, R L.
- Navarro, E F.
- Reilly, M O.
- Reule, M.
- Saxty, G.
- Seavers, L C.A.
- Smith, D M.
- Squires, M S.
- Trewartha, G.
- Walker, M T.
- Woodhead, A J.
- Woolford, A J.A.
- Wyatt, P G.
- Atp-binding
- Cell cycle
- Cell division
- Fragment screening
- Kinase
- Mitosis
- Nucleotide-binding
- Phosphoprotein
- Phosphorylation
- Polymorphism
- Protein kinase
- Serine/threonine protein kinase
- Serine/threonine-protein kinase
- Structure based drug design
- Transferase